galactose has been researched along with empagliflozin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Q; Fang, R; Huang, Q; Li, K; Li, S; Liu, D; Long, J; Zhang, B | 1 |
1 other study(ies) available for galactose and empagliflozin
| Article | Year |
|---|---|
Empagliflozin improves kidney senescence induced by D-galactose by reducing sirt1-mediated oxidative stress.
Topics: Animals; Cellular Senescence; Galactose; Glucose; Kidney; Mice; Oxidation-Reduction; Oxidative Stress; Sirtuin 1; Superoxide Dismutase-1 | 2023 |